Brief report: Etanercept inhibits the tumor necrosis factor α-driven shift of Th17 lymphocytes toward a nonclassic Th1 phenotype in juvenile idiopathic arthritis

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1372-1377

  Maggi, Laura ^a   Cimaz, Rolando ^b   Capone, Manuela ^a   Santarlasci, Veronica ^a   Querci, Valentina ^a   Simonini, Gabriele ^b   Nencini, Francesca ^a   Liotta, Francesco ^a   Romagnani, Sergio ^a   Maggi, Enrico ^a   Annunziato, Francesco ^a   Cosmi, Lorenzo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4 POSITIVE CD161 POSITIVE TH1 CELL; CD4 POSITIVE CD161 POSITIVE TH17 CELL; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLONE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE SUBPOPULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CYTOKINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOMODULATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR; TH1 CELLS; TH17 CELLS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899706888     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38355     Document Type: Article

References (16)

1. Ravelli A, Martini A,. Juvenile idiopathic arthritis. Lancet 2007; 369: 767-78.
2. Murray KJ, Luyrink L, Grom AA, Passo MH, Emery H, Witte D, et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996; 23: 2116-24.
3. De Jager W, Hoppenreijs EP, Wulffraat NM,. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007; 66: 589-98.
4. Miossec P,. Interleukin-17 and Th17 cells: from adult to juvenile arthritis-now it is serious! [editorial]. Arthritis Rheum 2011; 63: 2168-71.
5. Cosmi L, de Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, et al. Human interleukin-17-producing cells originate from a CD161+ CD4+ T-cell precursor. J Exp Med 2008; 205: 1903-16.
6. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010; 107: 14751-6.
7. Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 2504-15.
8. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al, Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342: 763-9.
9. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A,. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-9.
10. + T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125: 222-30.
11. Santarlasci V, Maggi L, Capone M, Querci V, Beltrame L, Cavalieri D, et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012; 36: 201-14.
12. Mills KH,. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008; 38: 2636-49.
13. Aerts NE, de Knop KJ, Leysen J, Ebo DG, Bridts CH, Weyler JJ, et al. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (Oxford) 2010; 49: 2264-72.
14. Maggi L, Santarlasci V, Capone M, Rossi MC, Querci V, Mazzoni A, et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells. Eur J Immunol 2012; 42: 3180-88.
15. Maggi L, Capone M, Giudici F, Santarlasci V, Querci V, Liotta F, et al. CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy. Int Arch Allergy Immunol 2012; 161: 81-6.
16. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S,. Defining the human T helper 17 cell phenotype. Trends Immunol 2012; 33: 505-12.